The nursing of subcutaneous injection of bortezomib therapy during hemodialysis for multiple myeloma combined with renal failure
Abstract：Objective:To summarize the nursing of subcutaneous injection of bortezomib therapy during hemodi-alysis for multiple myeloma patients combined with renal failure.Methods:Five patients with multiple myelo-ma combined with renal failure were treated by subcutaneous bortezomib with dexamethasone chemotherapy simultaneously during hemodialysis.To arrange the reasonable administration time and pay attention to psycho-logical care,hemodialysis catheter care,administration treatments,adverse drug reactions and other care.Re-sults:3 cases were complete remission,1 case was partial remission,and 1 case gave up treatment.The adverse reactions mainly included peripheral neuropathy,gastrointestinal reactions,bone marrow suppression,and fa-tigue.Conclusion:Bortezomib subcutaneous treatment has a good effect on multiple myeloma patients combined with renal failure.Ensured a close observation and in time treatment of adverse reactions,the patients could complete the treatment and promote the rehabilitation successfully.
Keywords：multiple myelomarenal failurebortezomibsubcutaneousnursing
Publication Date：2015-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 2841-2843 )